Keep Updated
Tech & Trends 2024
E-Book
A look ahead at some of the most exciting innovations and movements that are changing the industry as we know it.
- Keep up with the fast-moving biopharmaceutical markets
- See the developments that matter ahead of the competition
- Artificial intelligence (AI), the metaverse and other digital applications
Outlook 2024
Extract
Access the most powerful, comprehensive view of the year to come, including the predicted drug, device, and diagnostic catalysts.
- Key influences, deals, policies and therapies shaping 2024 and beyond
- Round-up of the must know topics from In Vivo’s flagship publication
- The latest and greatest across pharma, biotech, medtech and generics
#JPM24 Preview
Report
Before the conference kicks off, we’ve selected our picks of who to watch throughout the week.
- All the talking points at the world's most influential healthcare conference
- A sneak-peak at the 2024 agenda and presentations
- Key trends we expect to see at the conference
Daily Updates
Day Four
View the highlights and key developments from company presentations on day one.
- Highlights from company presentations included for Mega, Large, Mid and Small Cap companies
- Full list of events and catalysts which were announced or updated on the first day
Daily Deep Dive
Day Four
View the highlights and key developments from company presentations on day one.
- Highlights from company presentations included for Mega, Large, Mid and Small Cap companies
- Full list of events and catalysts which were announced or updated on the first day
Keep Updated
Medtech Insight
JPM24
For Illumina, the past year has been mostly a nightmare of its making. However, with Grail’s divestiture on the cards for 2024, stability may soon return to the company.
DownloadMedtech Insight
JPM24
The three genomics players all announced preliminary results prior to speaking, and all had more news to add about their recent success and their plans to grow the demand for cancer diagnostics.
Download
Medtech Insight
JPM24
The company has recorded impressive growth over the past year and issued strong guidance for the next. It has also announced plans for a new glucose monitor specifically targeting type II diabetics.
Download
Wrap-up Report
Get our full conference report to receive all of the essential information covered from the 2023 conference.
- Key takeaways and trends revealed at the #JPM24
- A complete recap of product updates from the conference
- Expert insights into company strategies, what’s in the pipeline, M&A activity, and deals
Request a Demo
In Vivo Demo
- Strategic insights for life sciences decision makers
- interviews, analysis and insights to inform your decision making
Scrip Demo
- Industry news and insights for commercial decision makers
- Focused, independent insight and opinion on market developments
DMHC Demo
- In-depth research and analysis of the pharma/biotech industries
- Support strategic plans and make more accurate commercial decisions
BMT Demo
- Real-time tracking and analysis of the drug development pipeline
- Catalyst tracking helps you stay on top of current biopharma events
How Can We Help
Comprehensive insights and data solutions
- Join the world’s top 50 pharmaceutical companies and top 10 contract research organizations
- Tap into essential data, insights, and analytics to inform your pharmaceutical portfolio
- Use the pharmaceutical clinical trial management software by Citeline suite to structure your strategy